Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-12
2005-04-12
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S169000, C514S320000, C514S323000, C514S324000, C514S326000, C544S333000, C546S193000, C546S197000, C546S199000, C546S201000, C546S202000, C546S209000, C546S210000, C548S400000
Reexamination Certificate
active
06878725
ABSTRACT:
Compounds of formula (I)in which R2, X, Y, Cy, L and Lp(D)nhave the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.
REFERENCES:
patent: 5346907 (1994-09-01), Kerwin et al.
patent: 6262069 (2001-07-01), Liebeschuetz et al.
patent: 6545055 (2003-04-01), Zhu et al.
patent: 20020151724 (2002-10-01), Liebeschuetz et al.
patent: 796866 (1997-09-01), None
patent: WO 9100725 (1991-01-01), None
patent: WO 9749404 (1997-12-01), None
patent: WO 9847876 (1998-10-01), None
patent: WO 9900121 (1999-01-01), None
patent: WO 9900126 (1999-01-01), None
patent: WO 9900127 (1999-01-01), None
patent: WO 9900128 (1999-01-01), None
patent: WO 9911657 (1999-03-01), None
patent: WO 9911658 (1999-03-01), None
patent: WO 0039092 (2000-07-01), None
patent: WO 0039111 (2000-07-01), None
patent: WO 0039117 (2000-07-01), None
patent: WO 0039118 (2000-07-01), None
patent: WO 0071493 (2000-11-01), None
patent: WO 0071507 (2000-11-01), None
patent: WO 0071508 (2000-11-01), None
patent: WO 0076971 (2000-12-01), None
patent: WO 0076970 (2002-12-01), None
patent: WO 0077027 (2002-12-01), None
Claims of U.S. Appl. No. 10/030,186.*
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Camp Nicholas Paul
Engel David Birenbaum
Jones Stuart Donald
Liebeschuetz John Walter
Masters John Joseph
Chang Celia
Eli Lilly and Company
Hay Martin A.
LandOfFree
Serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367124